Ambroxol


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 28.0%
Drug Abuse 23.9%
Chronic Obstructive Pulmonary Disease 8.4%
Hypertension 5.6%
Sedation 3.5%
Supplementation Therapy 2.9%
Osteoporosis 2.8%
Prophylaxis 2.7%
Psoas Abscess 2.6%
Pain 2.5%
Fluid Replacement 2.4%
Cardiac Disorder 2.3%
Alcohol Withdrawal Syndrome 1.9%
Atrial Fibrillation 1.8%
Coronary Artery Disease 1.8%
Thrombosis Prophylaxis 1.7%
Mucous Membrane Disorder 1.5%
Pneumonia 1.5%
Hyperglycaemia 1.3%
Bronchitis 1.0%
Toxic Epidermal Necrolysis 22.2%
Respiratory Failure 8.9%
Stevens-johnson Syndrome 8.9%
Diarrhoea 6.7%
Pruritus 6.7%
Drug Ineffective 4.4%
Dyspnoea 4.4%
Skin Reaction 4.4%
Surgery 4.4%
Toxic Skin Eruption 4.4%
Vomiting 4.4%
Back Pain 2.2%
Blood Bilirubin Increased 2.2%
Chest Discomfort 2.2%
Chorea 2.2%
Drug Interaction 2.2%
Haematuria 2.2%
Heart Rate Increased 2.2%
Mouth Ulceration 2.2%
Parkinsonism 2.2%
Concomitant
Product Used For Unknown Indication 24.7%
Prophylaxis 9.4%
Drug Use For Unknown Indication 7.5%
Hypertension 6.0%
Pneumonia 4.7%
Pain 4.6%
Infection Prophylaxis 4.5%
Bronchitis 4.0%
Non-small Cell Lung Cancer 4.0%
Premedication 3.7%
Chronic Obstructive Pulmonary Disease 3.4%
Cough 3.4%
Rheumatoid Arthritis 3.2%
Bronchopneumonia 2.9%
Prophylaxis Against Graft Versus Host Disease 2.9%
Diarrhoea 2.8%
Infection 2.6%
Atrial Fibrillation 2.5%
Nasopharyngitis 1.8%
Cardiac Failure 1.6%
Death 8.3%
Renal Failure 8.3%
Vomiting 7.6%
Rash 7.0%
Sepsis 7.0%
Renal Failure Acute 5.7%
Therapeutic Agent Toxicity 5.7%
Pneumonia Aspiration 5.1%
Pulmonary Embolism 5.1%
Idiopathic Thrombocytopenic Purpura 4.5%
Respiratory Failure 4.5%
Hepatic Failure 3.8%
Hepatic Function Abnormal 3.8%
Septic Shock 3.8%
Sinusitis 3.8%
Toxic Epidermal Necrolysis 3.8%
Cerebral Haemorrhage 3.2%
Multi-organ Failure 3.2%
Pneumonia 3.2%
Diplopia 2.5%

Drug Data